Log on / register
Feedback | Support | My details
Open AccessHighly AccessDebate

Methicillin-resistant Staphylococcus aureus (MRSA) in rehabilitation and chronic-care-facilities: what is the best strategy?

Patrica Minary-Dohen email, Pascale Bailly email, Xavier Bertrand email and Daniel Talon email

Service d'Hygiène Hospitalière, Centre Hospitalier Universitaire Jean Minjoz, Besançon, France

author email corresponding author email

BMC Geriatrics 2003, 3:5doi:10.1186/1471-2318-3-5

Published: 12 December 2003

Abstract

Background

The risk associated with methicillin-resistant Staphylococcus aureus (MRSA) has been decreasing for several years in intensive care departments, but is now increasing in rehabilitation and chronic-care-facilities (R-CCF). The aim of this study was to use published data and our own experience to discuss the roles of screening for MRSA carriers, the type of isolation to be implemented and the efficiency of chemical decolonization.

Discussion

Screening identifies over 90% of patients colonised with MRSA upon admission to R-CCF versus only 50% for intensive care units. Only totally dependent patients acquire MRSA. Thus, strict geographical isolation, as opposed to "social reinsertion", is clearly of no value. However, this should not lead to the abandoning of isolation, which remains essential during the administration of care. The use of chemicals to decolonize the nose and healthy skin appeared to be of some value and the application of this procedure could make technical isolation unnecessary in a non-negligible proportion of cases.

Summary

Given the increase in morbidity associated with MRSA observed in numerous hospitals, the emergence of a community-acquired disease associated with these strains and the evolution of glycopeptide-resistant strains, the voluntary application of a strategy combining screening, technical isolation and chemical decolonization in R-CCF appears to be an urgent matter of priority.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.